MS doctors and specialists at the Multiple Sclerosis Research Group (MSRG) Clinic have established a track record of cutting-edge care through the use of state-of-the-art techniques in the diagnosis, evaluation, management and treatment of adultpatients with demyelinating disorders in Houston.
Specialists at the Houston clinic are at the forefront of investigator-initiated research in MS, including:
- oral protein medications for the treatment of MS
- immune regulation in MS
- infections as a cause of MS
- MS-related MRI findings
- MS-related cognitive impairment
The Center also conducts investigator-initiated and pharmaceutical company sponsored clinical trials on novel agents for the treatment of MS and clinical research using imaging studies to investigate the evolution of MS pathology.
Houston's Leader in MS Research
Organized in 1983, Mischer Neuroscience Institute is a global leader in advanced image analysis for multiple sclerosis and the first and only center in Houston to direct national and international clinical trails in MS.
Our team of physicians has participated in more than 25 clinical trials of potential novel symptomatic and disease-modifying therapies. Several of these trials were pivotal in supporting FDA approval of treatments currently available for MS.
The Institute was the first in the world to conduct preclinical studies on the effects of combined therapy with immunomodulating drugs and to explore the effects of oralcytokines in modulating MS and type 1 diabetes.
Multiple Sclerosis Research Group (MSRG) Scope of Expertise
- Multiple sclerosis
- Demyelinating diseases including neuromyelitis optica, transverse myelitis and optic neuritis
The Multiple Sclerosis Research Group (MSRG) Clinic is a collaboration between Memorial Hermann-Texas Medical Center and The University of Texas Medical School at Houston.
The Multiple Sclerosis Research Group (MSRG) Clinic
UT Professional Building
6410 Fannin St
Houston, TX 77030